Abstract
Testing the biological activities of a dietary compound like resveratrol presents various challenges, which are highlighted in this commentary, with some suggested direction for future research, focusing on five challenges: (1) many different cellular effects are observed for resveratrol, but it is not known whether they arise from one point of action (or a few) or whether resveratrol is non-specific in its action; (2) the health-promotion effect of dietary resveratrol is likely a combinatory effect of various bioactive components in the mixture (diet); (3) the known cell biological response to resveratrol is presently based on exposure to short-term high levels, and better in vitro analyses have to be developed; (4) the actual level of resveratrol and resveratrol metabolites present in vitro and in vivo during experiments may be over- and underestimated, respectively, because resveratrol is not very soluble in water; and (5) only a few small clinical studies have been published to date, focusing on the therapeutic effects of resveratrol. Further, clinical trials addressing the disease-preventive effects are especially challenging.
Originalsprog | Engelsk |
---|---|
Tidsskrift | New York Academy of Sciences. Annals |
Vol/bind | 1348 |
Udgave nummer | 1 |
Sider (fra-til) | 161-170 |
ISSN | 0077-8923 |
DOI | |
Status | Udgivet - 28 aug. 2015 |
Emneord
- Resveratrol
- combinatory effect
- clinical trial
- biological targets